Cargando…

Risk category system to identify pituitary adenoma patients with AIP mutations

BACKGROUND: Predictive tools to identify patients at risk for gene mutations related to pituitary adenomas are very helpful in clinical practice. We therefore aimed to develop and validate a reliable risk category system for aryl hydrocarbon receptor-interacting protein (AIP) mutations in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caimari, Francisca, Hernández-Ramírez, Laura Cristina, Dang, Mary N, Gabrovska, Plamena, Iacovazzo, Donato, Stals, Karen, Ellard, Sian, Korbonits, Márta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Screening
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869708/ https://www.ncbi.nlm.nih.gov/pubmed/29440248 http://dx.doi.org/10.1136/jmedgenet-2017-104957

Ejemplares similares

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2015)

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
por: Marques, Pedro, et al.
Publicado: (2020)

Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
por: Igreja, Susana, et al.
Publicado: (2010)

An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene
por: Dinesen, Pia T, et al.
Publicado: (2015)

SAT-462 AIP Mutation-Positive Patients with Somatotropinomas End up Taller and Requiring Radiotherapy More Often Compared to AIP Mutation-Negative Patients: Data from 784 Familial and Young-Onset Cases
por: Marques, Pedro, et al.
Publicado: (2019)

In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism
por: Salvatori, Roberto, et al.
Publicado: (2017)

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
por: Morgan, Rhodri M. L., et al.
Publicado: (2012)

AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation
por: Araujo, Paula Bruna, et al.
Publicado: (2017)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family
por: Marques, Pedro, et al.
Publicado: (2018)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism
por: Imran, Syed Ali, et al.
Publicado: (2018)

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018)

Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2016)

Increased Population Risk of AIP‐Related Acromegaly and Gigantism in Ireland
por: Radian, Serban, et al.
Publicado: (2016)

Cantú syndrome with coexisting familial pituitary adenoma
por: Marques, Pedro, et al.
Publicado: (2018)

Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview
por: Bilbao Garay, Ismene, et al.
Publicado: (2020)

Apoplexy in sporadic pituitary adenomas: a single referral center experience and AIP mutation analysis
por: Fialho, Christhiane, et al.
Publicado: (2021)

Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child
por: Dutta, Pinaki, et al.
Publicado: (2019)

Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018)

AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020)

A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy
por: Ishii, Atsushi, et al.
Publicado: (2017)

Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England
por: He, Emily, et al.
Publicado: (2019)

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
por: Iacovazzo, Donato, et al.
Publicado: (2016)

Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort
por: Dénes, Judit, et al.
Publicado: (2015)

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
por: Kenna, Kevin P, et al.
Publicado: (2013)

Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations
por: Lerner-Ellis, Jordan, et al.
Publicado: (2015)

Can a print‐based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial
por: Carey, Mariko, et al.
Publicado: (2016)

Developing better strategies for school eye health screening in India
por: Reddy, Priya Adhisesha, et al.
Publicado: (2017)

Screening for ROP
por: Quinn, Graham, et al.
Publicado: (2017)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

A systematic review of health promotion interventions to increase breast cancer screening uptake: from the last 12 years
por: Agide, Feleke Doyore, et al.
Publicado: (2018)

Moving towards an organized cervical cancer screening: costs and impact
por: Diaz, Mireia, et al.
Publicado: (2018)

Effects of screening and universal healthcare on long-term colorectal cancer mortality
por: Lee, Yi-Chia, et al.
Publicado: (2019)

Number of prior negative screening outcomes does not influence future risk of breast cancer
por: Lilleborge, Marie, et al.
Publicado: (2020)

Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting
por: Bao, Minghui, et al.
Publicado: (2020)

Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data
por: Hüsing, Anika, et al.
Publicado: (2020)

Screening for caregiver psychosocial risk in children with medical complexity: a cross-sectional study
por: Verma, Rahul, et al.
Publicado: (2020)

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021)

Validity of self-reported mammography uptake in the Belgian health interview survey: selection and reporting bias
por: Berete, Finaba, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65lrblntibbag3c8j57957r1u4